Top Companies Developing Connected Drug Delivery Device
.png)
Published: January 2026
Medication non-adherence remains a critical global healthcare challenge, significantly influencing treatment efficacy, patient outcomes, and overall healthcare expenditure. As per the estimates by the WHO, nearly half of all patients fail to take their medications as prescribed. In the US alone, non-adherence to dosage regimens is associated with approximately 125,000 preventable deaths each year, alongside a considerable economic burden on the healthcare system. To address these concerns, the industry stakeholders have recognized the urgent need for developing innovative approaches to support patients in maintaining adherence to therapy. One of the most effective and rapidly evolving solutions is the integration of connected or smart drug delivery systems into routine clinical practice.
Connected drug delivery devices represent the convergence of traditional medication delivery methods with advanced digital technologies. These advanced devices enable precise dosing while simultaneously tracking and transmitting key usage data. Examples include smart inhalers, connected wearable injectors, and smart infusion pumps. By integrating sensors, wireless connectivity, and data analytics, such devices can record when and how a medication is administered, providing valuable insights into patient behavior.
As healthcare systems evolve worldwide, connected drug delivery devices are emerging as pivotal enablers of proactive, patient-centric care. Their increasing adoption represents a significant step toward intelligence-driven therapeutics that improve adherence, enhance clinical outcomes, and strengthen the overall efficiency and sustainability of drug delivery across diverse therapeutic areas.
Roots Analysis has conducted an exhaustive study on Connected Drug Delivery Devices Market featuring the current market landscape and future opportunity for the service providers involved in the connected drug delivery devices domain, over a span of 10 years.
Top Five Promising Companies Developing Connected Drug Delivery Devices
- Medtronic
- Insulet
- BIOCORP
- Gerresheimer
- Medtrum
The figure below highlights the top five companies offering smart / connected devices:
Interested in exploring all 85+ connected drug delivery devices companies and their recent initiatives?
Discover Below the Details on Top 5 Connected Drug Delivery Devices Companies Offering Connected / Smart Devices
Let us dive deep into the details of the top 5 connected drug delivery devices manufacturers offering connected / smart devices. It is essential to note that the selection of top players can differ substantially according to the defined criteria.
1. Medtronic
Company Overview
Medtronic is a US-based firm focused on developing innovative diagnostic and therapeutic solutions for over 70 disease indications. The company offers a broad range of medical devices, including cardiac devices, insulin pumps, patient monitoring systems, and surgical robotics and tools. Leveraging its rich experience in the field of drug delivery devices, the firm offers various solutions for efficient diabetes control. It is interesting to note that, over 70 million patients (across various countries) have reportedly received treatment through the wide array of products offered by the company. Notably, the firm has filed more than 46,000 patents for a myriad of products.
List of Connected Drug Delivery Devices Portfolio
The section provides information on the various connected drug delivery devices offered by Medtronic, along with details on stage of development, launch year, regulatory approvals, class of device, type of integrated device, route of administration, target indication, therapeutic area, key features, mode of connectivity, and availability of companion mobile application.
| Connected / Smart Drug Delivery Device |
Details |
| MiniMed 670G Insulin Pump System |
|
| MiniMed 640G Insulin Pump System |
|
| MiniMed 780G Advanced Hybrid Closed Loop System |
|
| InPen Smart Insulin Pen System |
|
Recent Development:
In September 2025, Medtronic announced the pricing of EUR 1.5 billion senior notes.
To know more about the recent initiatives of Medtronic and other connected drug delivery devices companies, access full report.
2. Insulet
Company Overview
Insulet is engaged in developing novel medical devices for diabetic patients and other conditions. The firm’s proprietary insulin management system, namely Omnipod comprises small, self-adhesive, tubeless device (Pod), which can be worn directly on the body; it also includes wireless companion, handheld Personal Diabetes Manager (PDM), and a built-in blood glucose meter (allowing users to conveniently monitor their blood glucose levels at any given moment). Notably, the system allows for up to three days of continuous insulin delivery, without the need to see or touch a needle. Further, the firm claims that its products are available in over 25 countries across North America, Europe, Asia Pacific and Middle East.
List of Connected Drug Delivery Devices Portfolio
The section provides information on the various connected drug delivery devices offered by Insulet, along with details on stage of development, launch year, regulatory approvals, class of device, type of integrated device, route of administration, target indication, therapeutic area, key features, mode of connectivity, and availability of companion mobile application.
| Connected / Smart Drug Delivery Device |
Details |
| Omnipod DASH System |
|
| Omnipod 5 System |
|
Recent Development:
In January 2026, Insulet showcased its automated insulin delivery (AID) technology at the Consumer Electronics Show (CES) 2026 held in Las Vegas.
To know more about the recent initiatives of Insulet and other connected drug delivery devices companies, access full report.
3. BIOCORP
Company Overview
BIOCORP (acquired by Novo Nordisk) is a French company engaged in the design, development and manufacturing of pharmaceutical devices and connected devices. The company’s connected devices employ advanced technologies (such as IoT connectivity) to receive and transmit data for monitoring and analyzing purposes. Further, it offers customized solutions to its clients, such as dosage systems (droppers, pipettes and spoons), dispensing systems (cannulas, dosing caps and mouthwashes) and related accessories (backstops, connectors and needle shields). Additionally, the firm strives to develop novel and high-quality products and adapt to ongoing technological advancements.
List of Connected Drug Delivery Devices Portfolio
The section provides information on the various connected drug delivery devices offered by BIOCORP, along with details on stage of development, launch year, regulatory approvals, class of device, type of integrated device, route of administration, target indication, therapeutic area, key features, mode of connectivity, and availability of companion mobile application.
| Connected / Smart Drug Delivery Device |
Details |
| Datapen |
|
| Onejet |
|
| Injay |
|
| SoloSmart |
|
| Mallya |
|
| Inspair |
|
To know more about the recent initiatives of BIOCORP and other connected drug delivery devices companies, access full report.
4. Gerresheimer
Company Overview
Gerresheimer is a biopharmaceutical company specializing in the development and manufacturing of advanced drug delivery systems, pharmaceutical containment systems, and medical devices. The product portfolio of the firm includes insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines. Further, the firm claims to have 36 production sites and global presence across America, Asia and Europe. Renowned for innovation, Gerresheimer supports CDMOs in producing high-quality glass and polymer solutions for biologics, vaccines, and precision therapies like ADCs.
List of Connected Drug Delivery Devices Portfolio
The section provides information on the various connected drug delivery devices offered by Gerresheimer, along with details on stage of development, launch year, regulatory approvals, class of device, type of integrated device, route of administration, target indication, therapeutic area, key features, mode of connectivity, and availability of companion mobile application.
| Connected / Smart Drug Delivery Device |
Details |
| D–mine Pump |
|
| Respimetrix Inhalation Assessment Platform |
|
| Gx SensAirR Drug Delivery Device |
|
| Patch Pump – Small Volume Injector on-body |
|
Recent Development:
In September 2025, Gerresheimer expanded its collaboration with Portal Instruments to commercialize the latter company’s reusable autoinjector platform. This partnership combines Portal's innovative device technology with Gerresheimer's expertise in primary packaging and large-scale manufacturing.
To know more about the recent initiatives of Gerresheimer and other connected drug delivery devices companies, access full report.
5. Medtrum
Company Overview
Medtrum is engaged in the development of medical devices, primarily catering to the needs of patients suffering from diabetes. The firm’s primary focus is to develop a closed-loop artificial pancreas that can simplify diabetes management. Additionally, the company has developed tubeless insulin pumps, continuous glucose monitoring systems (along with companion mobile applications) for both home care and clinic use.
List of Connected Drug Delivery Devices Portfolio
The section provides information on the various connected drug delivery devices offered by Medtrum, along with details on stage of development, launch year, regulatory approvals, class of device, type of integrated device, route of administration, target indication, therapeutic area, key features, mode of connectivity, and availability of companion mobile application.
| Connected / Smart Drug Delivery Device |
Details |
| P6 EasyPatch Disposable Pump |
|
| S7 EasySense CGM System |
|
| A6 TouchCare CGM |
|
Recent Development:
In December 2025, Medtrum launched the 300-unit version of its tubeless insulin patch pump, addressing needs for higher total daily dose (TDD) users by reducing reservoir changes and extending wear time up to three days.
To know more about the recent initiatives of Medtrum and other connected drug delivery devices companies, access full report.
What About Other Connected Drug Delivery Device Companies Around the World?
The above article features the top five connected drug delivery device companies selected from a pool of 85+ companies that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.
Sources
- https://news.medtronic.com/2025-09-15-Medtronic-Announces-Pricing-of-EUR1-5-Billion-of-Senior-Notes
- https://www.drugdeliverybusiness.com/insulet-debuts-ces-2026/
- https://www.gerresheimer.com/en/customer/company/news/detail/gerresheimer-expands-collaboration-with-portal-instruments-for-commercialization-of-the-prime-nexustm-reusable-autoinjector
- https://www.drugdeliverybusiness.com/medtrum-introduces-300u-tubeless-insulin-pump/